Multiplex method for increased proteomic coverage from histopathologically processed biological samples, tissues cells
The invention provides methods for multiplex analysis of biological samples of formalin-fixed tissue samples. The invention provides for a method to achieve a multiplexed, multi-staged plurality of Liquid Tissue preparations simultaneously from a single histopathologically processed biological sample, where the protocol for each Liquid Tissue preparation imparts a distinctive set of biochemical effects on biomolecules procured from histopathologically processed biological samples and which when each of the preparations is analyzed can render additive and complementary data about the same histopathologically processed biological sample.
1. A method of generating a multiplexed biomolecule lysate, comprising the steps of:
(a) contacting a first histopathologically processed biological sample with a first buffer solution and a second histopathologically processed biological sample with a second buffer solution;
(b) heating said first histopathologically processed biological sample and second histopathologically processed biological sample at a temperature and for a time sufficient to substantially reduce the protein cross-links present in the biological samples to form heated first and second samples;
(c) treating the heated first and second samples with an effective amount of one or more proteolytic enzymes for a time sufficient to substantially duce the proteins to individual peptides; and
(d) separating the first sample contacted with said amount of one or more proteolytic enzymes using a first separation system and separating the second sample contacted with said amount of one or more proteolytic enzymes using a second separation system wherein the first separation system and the second separation system separately comprise a chromatography matrix;
thereby generating said multiplexed biomolecule lysate.
2. The method of claim 1 , further comprising the step of detecting the presence of least one protein analyte in the first sample contacted with said one or more proteolytic enzymes and at least one protein analyte in the second sample contacted with said one or more proteolytic enzymes.
3. The method of claim 1 , wherein the first buffer is chemically distinct from the second buffer.
4. The method of claim 2 , wherein the detection comprises mass spectrometry, immunohistochemistry, ELISA, Western blotting, polyacrylamide gel electrophoresis, synthetic aptamer binding analysis, or isoelectric focusing analysis.
5. The method of claim 2 , wherein the detecting is by a mass spectrometric selected from the group consisting of matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF), liquid chromatography electrospray ionization tandem mass spectrometry (LC-ESI -MS/MS), or surface enhanced laser desorption ionization (SELDI) mass spectrometry.
6. The method of claim 2 , further comprising comparing the analytes detected in the first and second samples with one or more reference analytes.
7. The method of claim 1 , wherein the first separation system is distinct from the second separation system.
8. The method of claim 1 , further comprising comparing the analytes detected in the first and second samples with one or more reference analytes.
9. The method of claim 1 , wherein the reference analyte is obtained from a subject having a disease or condition.
10. The method of claim 1 , wherein the first biological sample and the second biological sample comprise adjacent serial sections.
11. The multiplexed biomolecule lysate generated by the method of claim 1 .
12. A method of analyzing a tissue proteome, comprising the steps of:
(a) contacting a first histopathologically processed biological sample with a first buffer solution and a second histopathologically processed biological sample with a second buffer solution;
(b) heating said first histopathologically processed biological sample and second histopathologically processed biological sample at a temperature and for a time sufficient to substantially reduce the protein cross-links present in the biological samples to form heated first and second samples;
(c) treating the heated first and second samples with an effective amount of one or more proteolytic enzymes for a time sufficient to substantially reduce the proteins to individual peptides;
(d) separating the first sample using a first separation system and separating the second sample using a second separation system wherein the first separation system and the second separation system separately comprise a chromatography matrix; and
(e) detecting the presence of at least one protein analyte in each of the first and second treated samples,
thereby analyzing a tissue proteome.
13. The method of claim 12 , wherein the first biological sample and the second biological sample comprise adjacent serial sections.
14. The method of claim 12 , comprising at least n biological samples and n buffer conditions, wherein n is a positive whole number between 3 and 100.